iGMDRD582


Canonical SMILES: B(C(CC(C)C)NC(=O)CNC(=O)C1=C(C=CC(=C1)Cl)Cl)(O)O

InChI: InChI=1S/C14H19BCl2N2O4/c1-8(2)5-12(15(22)23)19-13(20)7-18-14(21)10-6-9(16)3-4-11(10)17/h3-4,6,8,12,22-23H,5,7H2,1-2H3,(H,18,21)(H,19,20)/t12-/m0/s1

InChI Key: MXAYKZJJDUDWDS-LBPRGKRZSA-N

Loading, please wait...
Standard Name
CHEMBL
Pubchem CID
DRUGBANK ID
Drug Status
Drug Type
Standard NameMLN 2238
Pubchem CID25183900
DRUGBANK IDDB09570
Drug StatusAlone
Drug TypeSmall Molecule


Drug Targets:

PSMB5

Drug-model tissue-cancer distribution: Bubble Plot

OVARtissue: OVAR cancer: OVARY model num: 0OVARYtissue: OVARY cancer: undefined model num: 1undefinetissue: undefine cancer: undefined model num: 0undefinedtissue: undefined cancer: PANCAN model num: 7BOWEtissue: BOWE cancer: BOWEL model num: 0BOWELtissue: BOWEL cancer: Colorectal Cancer model num: 1

Drug-gene pathway enrichments

5reactome: Signal Transduction3kegg: HTLV-I infection - Homo sapiens (human)3wikipathways: EGF-EGFR Signaling Pathway2reactome: Signaling by NTRK1 (TRKA)2kegg: Hepatitis B - Homo sapiens (human)2kegg: Human papillomavirus infection - Homo sapiens (human)2reactome: Mismatch Repair2reactome: Metabolism of proteins2kegg: Insulin signaling pathway - Homo sapiens (human)2reactome: Generic Transcription Pathway

Drug-gene GO enrichments

5MF: protein binding5CC: cytoplasm5CC: cytosol5CC: nucleus3BP: translesion synthesis3BP: protein export from nucleus3CC: nucleoplasm3BP: mismatch repair2BP: negative regulation of neuron apoptotic process2CC: PCNA complex

Drug-Gene: Aster Plot


Loading, please wait...
Gene ID
Gene Name
Model Num.
7514 XPO1 1
3845 KRAS 1
1978 EIF4EBP1 1
7301 TYRO3 1
Showing 1 to 4 of 5 rows

Gene in drug-gene network: Network Plot

PIK-75PIK-75DC-45-A2DC-45-A2BRD6368BRD6368BRD7137BRD7137ursolic acidursolic acidEIF4EBP1EIF4EBP1kinetin ribosidekinetin ribosidetipifarnib-P2tipifarnib-P2navitoclaxnavitoclaxserdemetanserdemetanCompound.1541ACompound.1541AGW-843682XGW-843682XnakiterpiosinnakiterpiosinCyanoquinoline, 11Cyanoquinoline, 11FedratinibFedratinibavrainvillamideavrainvillamideGMX1778GMX1778gossypolgossypolpiperlonguminepiperlonguminezebularinezebularinePAC-1PAC-1CHM-1CHM-1TYRO3TYRO3PP-30PP-30selumetinib in BRAF mutant tumorsselumetinib in BRAF mutant tumorsMEK inhibitorsMEK inhibitorsGefitnibGefitnibCHEMBL399379CHEMBL399379cetuximabcetuximabBMS-536924BMS-536924ErlotinibErlotinibPanitumumabPanitumumabPD0325901PD0325901NSC141540NSC141540PI3K pathway inhibitorsPI3K pathway inhibitorsSarcolysinSarcolysinRefametinibRefametinibRegorafenibRegorafenibTrametinibTrametinibKRASKRASBI-2536BI-2536AZD-1775AZD-1775PaclitaxelPaclitaxelGSK-461364GSK-461364XL-880XL-880PF 184PF 184XPO1XPO1PCNAPCNAMLN 2238MLN 2238

Models in MLN 2238

Loading, please wait...
Model
Level
Reference ID
Tissue
Cancer
Drug
Clinical Response
Source
No matching records found

​​​​